nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ABCC3—lung cancer	0.193	0.592	CbGaD
Conjugated Estrogens—ABCG2—lung cancer	0.094	0.288	CbGaD
Conjugated Estrogens—ABCB1—lung cancer	0.0391	0.12	CbGaD
Conjugated Estrogens—ABCC11—Methotrexate—lung cancer	0.0313	0.07	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—lung cancer	0.0215	0.0481	CbGbCtD
Conjugated Estrogens—SLCO2B1—Erlotinib—lung cancer	0.0181	0.0404	CbGbCtD
Conjugated Estrogens—SLCO1B3—Paclitaxel—lung cancer	0.0147	0.0329	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—lung cancer	0.0137	0.0307	CbGbCtD
Conjugated Estrogens—ABCG2—Topotecan—lung cancer	0.0137	0.0307	CbGbCtD
Conjugated Estrogens—ABCC3—Cisplatin—lung cancer	0.0133	0.0298	CbGbCtD
Conjugated Estrogens—ABCC3—Etoposide—lung cancer	0.0131	0.0293	CbGbCtD
Conjugated Estrogens—ABCG2—Gefitinib—lung cancer	0.0125	0.0281	CbGbCtD
Conjugated Estrogens—ABCG2—Teniposide—lung cancer	0.0122	0.0272	CbGbCtD
Conjugated Estrogens—SLCO1B3—Docetaxel—lung cancer	0.0106	0.0238	CbGbCtD
Conjugated Estrogens—ABCC1—Paclitaxel—lung cancer	0.0101	0.0227	CbGbCtD
Conjugated Estrogens—ABCC1—Irinotecan—lung cancer	0.01	0.0224	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—lung cancer	0.00891	0.02	CbGbCtD
Conjugated Estrogens—ABCC1—Vinblastine—lung cancer	0.0089	0.0199	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—lung cancer	0.00863	0.0193	CbGbCtD
Conjugated Estrogens—SLCO1B1—Irinotecan—lung cancer	0.00843	0.0189	CbGbCtD
Conjugated Estrogens—ABCC1—Etoposide—lung cancer	0.00802	0.018	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—lung cancer	0.00766	0.0172	CbGbCtD
Conjugated Estrogens—ABCC2—Paclitaxel—lung cancer	0.00751	0.0168	CbGbCtD
Conjugated Estrogens—ABCG2—Erlotinib—lung cancer	0.00742	0.0166	CbGbCtD
Conjugated Estrogens—ABCC2—Irinotecan—lung cancer	0.00741	0.0166	CbGbCtD
Conjugated Estrogens—ABCC1—Docetaxel—lung cancer	0.00734	0.0164	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—lung cancer	0.00708	0.0159	CbGbCtD
Conjugated Estrogens—ABCG2—Paclitaxel—lung cancer	0.00679	0.0152	CbGbCtD
Conjugated Estrogens—ABCG2—Irinotecan—lung cancer	0.0067	0.015	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—lung cancer	0.00659	0.0148	CbGbCtD
Conjugated Estrogens—ABCC2—Vinblastine—lung cancer	0.00659	0.0148	CbGbCtD
Conjugated Estrogens—ABCC2—Cisplatin—lung cancer	0.00604	0.0135	CbGbCtD
Conjugated Estrogens—ABCC2—Etoposide—lung cancer	0.00594	0.0133	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—lung cancer	0.00547	0.0122	CbGbCtD
Conjugated Estrogens—ABCG2—Cisplatin—lung cancer	0.00546	0.0122	CbGbCtD
Conjugated Estrogens—ABCC2—Docetaxel—lung cancer	0.00543	0.0122	CbGbCtD
Conjugated Estrogens—ABCG2—Etoposide—lung cancer	0.00537	0.012	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—lung cancer	0.0053	0.0119	CbGbCtD
Conjugated Estrogens—ABCB1—Topotecan—lung cancer	0.00495	0.0111	CbGbCtD
Conjugated Estrogens—ABCG2—Docetaxel—lung cancer	0.00491	0.011	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—lung cancer	0.00473	0.0106	CbGbCtD
Conjugated Estrogens—ABCB1—Gefitinib—lung cancer	0.00452	0.0101	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—lung cancer	0.00446	0.01	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—lung cancer	0.00412	0.00923	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—lung cancer	0.00405	0.00907	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—lung cancer	0.00392	0.00878	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—lung cancer	0.00366	0.0082	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—lung cancer	0.00355	0.00794	CbGbCtD
Conjugated Estrogens—ABCB1—Vinorelbine—lung cancer	0.00349	0.00781	CbGbCtD
Conjugated Estrogens—CYP1A2—Erlotinib—lung cancer	0.00306	0.00685	CbGbCtD
Conjugated Estrogens—CYP3A4—Topotecan—lung cancer	0.00296	0.00664	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—lung cancer	0.00287	0.00643	CbGbCtD
Conjugated Estrogens—ABCB1—Crizotinib—lung cancer	0.00277	0.00621	CbGbCtD
Conjugated Estrogens—CYP3A4—Gefitinib—lung cancer	0.00271	0.00607	CbGbCtD
Conjugated Estrogens—ABCB1—Gemcitabine—lung cancer	0.00271	0.00607	CbGbCtD
Conjugated Estrogens—ABCB1—Erlotinib—lung cancer	0.00268	0.00599	CbGbCtD
Conjugated Estrogens—CYP3A4—Teniposide—lung cancer	0.00263	0.00589	CbGbCtD
Conjugated Estrogens—ABCB1—Paclitaxel—lung cancer	0.00245	0.00548	CbGbCtD
Conjugated Estrogens—ABCC11—mammary gland—lung cancer	0.00244	0.0926	CbGeAlD
Conjugated Estrogens—ABCB1—Irinotecan—lung cancer	0.00242	0.00541	CbGbCtD
Conjugated Estrogens—CYP1A2—Etoposide—lung cancer	0.00221	0.00496	CbGbCtD
Conjugated Estrogens—ABCB1—Vinblastine—lung cancer	0.00215	0.00481	CbGbCtD
Conjugated Estrogens—CYP3A4—Vinorelbine—lung cancer	0.00209	0.00468	CbGbCtD
Conjugated Estrogens—ABCB1—Cisplatin—lung cancer	0.00197	0.00441	CbGbCtD
Conjugated Estrogens—ABCB1—Etoposide—lung cancer	0.00194	0.00433	CbGbCtD
Conjugated Estrogens—ABCB1—Docetaxel—lung cancer	0.00177	0.00397	CbGbCtD
Conjugated Estrogens—CYP3A4—Crizotinib—lung cancer	0.00166	0.00372	CbGbCtD
Conjugated Estrogens—CYP3A4—Erlotinib—lung cancer	0.0016	0.00359	CbGbCtD
Conjugated Estrogens—CYP3A4—Paclitaxel—lung cancer	0.00147	0.00329	CbGbCtD
Conjugated Estrogens—CYP3A4—Irinotecan—lung cancer	0.00145	0.00324	CbGbCtD
Conjugated Estrogens—ABCB1—Doxorubicin—lung cancer	0.00132	0.00296	CbGbCtD
Conjugated Estrogens—CYP3A4—Vinblastine—lung cancer	0.00129	0.00288	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—lung cancer	0.00128	0.00286	CbGbCtD
Conjugated Estrogens—CYP3A4—Etoposide—lung cancer	0.00116	0.0026	CbGbCtD
Conjugated Estrogens—SLC51A—bronchus—lung cancer	0.00108	0.0408	CbGeAlD
Conjugated Estrogens—CYP3A4—Docetaxel—lung cancer	0.00106	0.00238	CbGbCtD
Conjugated Estrogens—SLC51B—lung—lung cancer	0.000969	0.0368	CbGeAlD
Conjugated Estrogens—SLC51A—trachea—lung cancer	0.000966	0.0367	CbGeAlD
Conjugated Estrogens—SLCO4A1—mammary gland—lung cancer	0.000958	0.0364	CbGeAlD
Conjugated Estrogens—ESR2—mammary gland—lung cancer	0.00085	0.0322	CbGeAlD
Conjugated Estrogens—SLCO1B1—mammary gland—lung cancer	0.000843	0.032	CbGeAlD
Conjugated Estrogens—CYP3A4—Doxorubicin—lung cancer	0.000791	0.00177	CbGbCtD
Conjugated Estrogens—SLCO2B1—mammary gland—lung cancer	0.000745	0.0283	CbGeAlD
Conjugated Estrogens—SLC51A—lung—lung cancer	0.000694	0.0264	CbGeAlD
Conjugated Estrogens—ESR1—mammary gland—lung cancer	0.000582	0.0221	CbGeAlD
Conjugated Estrogens—SLCO3A1—bronchus—lung cancer	0.000577	0.0219	CbGeAlD
Conjugated Estrogens—ESR2—respiratory system—lung cancer	0.000566	0.0215	CbGeAlD
Conjugated Estrogens—COMT—respiratory system—lung cancer	0.00054	0.0205	CbGeAlD
Conjugated Estrogens—ABCC3—respiratory system—lung cancer	0.000533	0.0202	CbGeAlD
Conjugated Estrogens—SLCO4A1—bronchus—lung cancer	0.000525	0.0199	CbGeAlD
Conjugated Estrogens—SLCO1B3—lung—lung cancer	0.000516	0.0196	CbGeAlD
Conjugated Estrogens—SLCO2B1—respiratory system—lung cancer	0.000497	0.0189	CbGeAlD
Conjugated Estrogens—SLCO3A1—cardiac atrium—lung cancer	0.000486	0.0185	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—lung cancer	0.000475	0.018	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—lung cancer	0.000473	0.018	CbGeAlD
Conjugated Estrogens—SLCO4A1—trachea—lung cancer	0.000472	0.0179	CbGeAlD
Conjugated Estrogens—COMT—bronchus—lung cancer	0.000444	0.0169	CbGeAlD
Conjugated Estrogens—SLCO4A1—cardiac atrium—lung cancer	0.000443	0.0168	CbGeAlD
Conjugated Estrogens—COMT—trachea—lung cancer	0.000399	0.0151	CbGeAlD
Conjugated Estrogens—ESR1—respiratory system—lung cancer	0.000388	0.0147	CbGeAlD
Conjugated Estrogens—COMT—cardiac atrium—lung cancer	0.000375	0.0142	CbGeAlD
Conjugated Estrogens—SLCO3A1—lung—lung cancer	0.000372	0.0141	CbGeAlD
Conjugated Estrogens—ABCC4—bronchus—lung cancer	0.000362	0.0137	CbGeAlD
Conjugated Estrogens—SLCO4A1—lung—lung cancer	0.000339	0.0129	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—lung cancer	0.000324	0.0123	CbGeAlD
Conjugated Estrogens—COMT—bone marrow—lung cancer	0.000316	0.012	CbGeAlD
Conjugated Estrogens—ABCC1—bronchus—lung cancer	0.000309	0.0117	CbGeAlD
Conjugated Estrogens—ESR2—lung—lung cancer	0.000301	0.0114	CbGeAlD
Conjugated Estrogens—CYP1A2—respiratory system—lung cancer	0.000299	0.0113	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—lung cancer	0.000289	0.011	CbGeAlD
Conjugated Estrogens—COMT—lung—lung cancer	0.000287	0.0109	CbGeAlD
Conjugated Estrogens—ABCC3—lung—lung cancer	0.000283	0.0107	CbGeAlD
Conjugated Estrogens—ABCC1—trachea—lung cancer	0.000277	0.0105	CbGeAlD
Conjugated Estrogens—SLCO2B1—lung—lung cancer	0.000264	0.01	CbGeAlD
Conjugated Estrogens—ABCC1—cardiac atrium—lung cancer	0.00026	0.00989	CbGeAlD
Conjugated Estrogens—ABCC4—bone marrow—lung cancer	0.000258	0.00979	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—lung cancer	0.000254	0.00966	CbGeAlD
Conjugated Estrogens—SLCO1A2—lung—lung cancer	0.000243	0.00922	CbGeAlD
Conjugated Estrogens—ABCC4—lung—lung cancer	0.000234	0.00887	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—lung cancer	0.000232	0.0088	CbGeAlD
Conjugated Estrogens—Estradiol—UGT1A1—lung cancer	0.000222	0.14	CrCbGaD
Conjugated Estrogens—ESR1—lung—lung cancer	0.000206	0.00782	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—lung cancer	0.000206	0.00781	CbGeAlD
Conjugated Estrogens—ABCC1—lung—lung cancer	0.000199	0.00756	CbGeAlD
Conjugated Estrogens—COMT—lymph node—lung cancer	0.000196	0.00744	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—lung cancer	0.000194	0.00735	CbGeAlD
Conjugated Estrogens—ABCG2—bone marrow—lung cancer	0.000182	0.00691	CbGeAlD
Conjugated Estrogens—SLCO2B1—lymph node—lung cancer	0.00018	0.00685	CbGeAlD
Conjugated Estrogens—ABCG2—lung—lung cancer	0.000165	0.00626	CbGeAlD
Conjugated Estrogens—Estrone—ABCG2—lung cancer	0.000164	0.104	CrCbGaD
Conjugated Estrogens—ABCC4—lymph node—lung cancer	0.00016	0.00607	CbGeAlD
Conjugated Estrogens—CYP1A2—lung—lung cancer	0.000159	0.00603	CbGeAlD
Conjugated Estrogens—ABCC2—lymph node—lung cancer	0.000155	0.00587	CbGeAlD
Conjugated Estrogens—ABCB1—respiratory system—lung cancer	0.000153	0.00581	CbGeAlD
Conjugated Estrogens—Estriol—ABCB1—lung cancer	0.000144	0.0907	CrCbGaD
Conjugated Estrogens—ESR1—lymph node—lung cancer	0.000141	0.00535	CbGeAlD
Conjugated Estrogens—ABCC1—lymph node—lung cancer	0.000136	0.00517	CbGeAlD
Conjugated Estrogens—Estramustine—ABCB1—lung cancer	0.000134	0.0843	CrCbGaD
Conjugated Estrogens—Estrone—CYP2E1—lung cancer	0.00013	0.0823	CrCbGaD
Conjugated Estrogens—Estrone—CYP1A1—lung cancer	0.000129	0.0812	CrCbGaD
Conjugated Estrogens—ABCB1—epithelium—lung cancer	0.000128	0.00486	CbGeAlD
Conjugated Estrogens—Estradiol—ABCG2—lung cancer	0.000125	0.0786	CrCbGaD
Conjugated Estrogens—Estropipate—ALB—lung cancer	0.000115	0.0727	CrCbGaD
Conjugated Estrogens—ABCB1—trachea—lung cancer	0.000113	0.0043	CbGeAlD
Conjugated Estrogens—ABCG2—lymph node—lung cancer	0.000113	0.00428	CbGeAlD
Conjugated Estrogens—Estradiol—CYP1A1—lung cancer	9.75e-05	0.0616	CrCbGaD
Conjugated Estrogens—ABCB1—bone marrow—lung cancer	8.98e-05	0.00341	CbGeAlD
Conjugated Estrogens—ABCB1—lung—lung cancer	8.13e-05	0.00309	CbGeAlD
Conjugated Estrogens—Ethinyl Estradiol—ABCB1—lung cancer	7.85e-05	0.0496	CrCbGaD
Conjugated Estrogens—Estrone—ALB—lung cancer	7.16e-05	0.0452	CrCbGaD
Conjugated Estrogens—Estrone—ABCB1—lung cancer	6.84e-05	0.0432	CrCbGaD
Conjugated Estrogens—ABCB1—lymph node—lung cancer	5.56e-05	0.00211	CbGeAlD
Conjugated Estrogens—Estradiol—ALB—lung cancer	5.43e-05	0.0343	CrCbGaD
Conjugated Estrogens—Estradiol—ABCB1—lung cancer	5.18e-05	0.0327	CrCbGaD
Conjugated Estrogens—Dysphagia—Doxorubicin—lung cancer	4.09e-05	0.000351	CcSEcCtD
Conjugated Estrogens—Palpitations—Docetaxel—lung cancer	4.04e-05	0.000346	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Etoposide—lung cancer	4.03e-05	0.000346	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Docetaxel—lung cancer	4.02e-05	0.000345	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Doxorubicin—lung cancer	4.01e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Paclitaxel—lung cancer	4.01e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Etoposide—lung cancer	4e-05	0.000343	CcSEcCtD
Conjugated Estrogens—Somnolence—Etoposide—lung cancer	3.99e-05	0.000342	CcSEcCtD
Conjugated Estrogens—Cough—Docetaxel—lung cancer	3.99e-05	0.000342	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—lung cancer	3.99e-05	0.000342	CcSEcCtD
Conjugated Estrogens—Insomnia—Paclitaxel—lung cancer	3.98e-05	0.000341	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Irinotecan—lung cancer	3.97e-05	0.000341	CcSEcCtD
Conjugated Estrogens—Convulsion—Docetaxel—lung cancer	3.96e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Paclitaxel—lung cancer	3.95e-05	0.000339	CcSEcCtD
Conjugated Estrogens—Bronchitis—Doxorubicin—lung cancer	3.94e-05	0.000338	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Paclitaxel—lung cancer	3.92e-05	0.000337	CcSEcCtD
Conjugated Estrogens—Somnolence—Paclitaxel—lung cancer	3.91e-05	0.000336	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Etoposide—lung cancer	3.9e-05	0.000335	CcSEcCtD
Conjugated Estrogens—Chest pain—Docetaxel—lung cancer	3.89e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Myalgia—Docetaxel—lung cancer	3.89e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Arthralgia—Docetaxel—lung cancer	3.89e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Nausea—Vinorelbine—lung cancer	3.88e-05	0.000333	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Etoposide—lung cancer	3.87e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Paclitaxel—lung cancer	3.87e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cisplatin—lung cancer	3.87e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Asthenia—Irinotecan—lung cancer	3.87e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Fatigue—Etoposide—lung cancer	3.87e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	3.86e-05	0.000331	CcSEcCtD
Conjugated Estrogens—Constipation—Etoposide—lung cancer	3.84e-05	0.000329	CcSEcCtD
Conjugated Estrogens—Pain—Etoposide—lung cancer	3.84e-05	0.000329	CcSEcCtD
Conjugated Estrogens—Dysuria—Doxorubicin—lung cancer	3.83e-05	0.000328	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Paclitaxel—lung cancer	3.82e-05	0.000328	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Doxorubicin—lung cancer	3.8e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Paclitaxel—lung cancer	3.8e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Fatigue—Paclitaxel—lung cancer	3.79e-05	0.000325	CcSEcCtD
Conjugated Estrogens—Asthenia—Gemcitabine—lung cancer	3.77e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Pain—Paclitaxel—lung cancer	3.76e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Constipation—Paclitaxel—lung cancer	3.76e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—lung cancer	3.75e-05	0.000322	CcSEcCtD
Conjugated Estrogens—Oedema—Docetaxel—lung cancer	3.73e-05	0.00032	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Docetaxel—lung cancer	3.73e-05	0.00032	CcSEcCtD
Conjugated Estrogens—Weight increased—Doxorubicin—lung cancer	3.72e-05	0.00032	CcSEcCtD
Conjugated Estrogens—Pruritus—Gemcitabine—lung cancer	3.72e-05	0.000319	CcSEcCtD
Conjugated Estrogens—Infection—Docetaxel—lung cancer	3.7e-05	0.000318	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Doxorubicin—lung cancer	3.69e-05	0.000317	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Irinotecan—lung cancer	3.69e-05	0.000317	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Etoposide—lung cancer	3.67e-05	0.000315	CcSEcCtD
Conjugated Estrogens—Shock—Docetaxel—lung cancer	3.67e-05	0.000315	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Docetaxel—lung cancer	3.66e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Doxorubicin—lung cancer	3.65e-05	0.000313	CcSEcCtD
Conjugated Estrogens—Infestation—Doxorubicin—lung cancer	3.65e-05	0.000313	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—lung cancer	3.65e-05	0.000313	CcSEcCtD
Conjugated Estrogens—Tachycardia—Docetaxel—lung cancer	3.64e-05	0.000312	CcSEcCtD
Conjugated Estrogens—Skin disorder—Docetaxel—lung cancer	3.62e-05	0.000311	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cisplatin—lung cancer	3.61e-05	0.00031	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Paclitaxel—lung cancer	3.6e-05	0.000309	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Gemcitabine—lung cancer	3.6e-05	0.000308	CcSEcCtD
Conjugated Estrogens—Renal failure—Doxorubicin—lung cancer	3.59e-05	0.000308	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—lung cancer	3.58e-05	0.000307	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Doxorubicin—lung cancer	3.58e-05	0.000307	CcSEcCtD
Conjugated Estrogens—Dizziness—Irinotecan—lung cancer	3.57e-05	0.000306	CcSEcCtD
Conjugated Estrogens—Urticaria—Etoposide—lung cancer	3.56e-05	0.000306	CcSEcCtD
Conjugated Estrogens—Anorexia—Docetaxel—lung cancer	3.55e-05	0.000305	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Etoposide—lung cancer	3.55e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Etoposide—lung cancer	3.55e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—lung cancer	3.54e-05	0.000303	CcSEcCtD
Conjugated Estrogens—Asthenia—Cisplatin—lung cancer	3.51e-05	0.000301	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—lung cancer	3.51e-05	0.000301	CcSEcCtD
Conjugated Estrogens—Urticaria—Paclitaxel—lung cancer	3.49e-05	0.0003	CcSEcCtD
Conjugated Estrogens—Hypotension—Docetaxel—lung cancer	3.48e-05	0.000299	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Paclitaxel—lung cancer	3.48e-05	0.000298	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Paclitaxel—lung cancer	3.48e-05	0.000298	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—lung cancer	3.45e-05	0.000296	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—lung cancer	3.43e-05	0.000294	CcSEcCtD
Conjugated Estrogens—Vomiting—Irinotecan—lung cancer	3.43e-05	0.000294	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—lung cancer	3.42e-05	0.000294	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—lung cancer	3.42e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—lung cancer	3.41e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Rash—Irinotecan—lung cancer	3.4e-05	0.000292	CcSEcCtD
Conjugated Estrogens—Dermatitis—Irinotecan—lung cancer	3.4e-05	0.000292	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Docetaxel—lung cancer	3.4e-05	0.000291	CcSEcCtD
Conjugated Estrogens—Headache—Irinotecan—lung cancer	3.38e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Insomnia—Docetaxel—lung cancer	3.37e-05	0.000289	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cisplatin—lung cancer	3.35e-05	0.000288	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Docetaxel—lung cancer	3.35e-05	0.000287	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—lung cancer	3.34e-05	0.000287	CcSEcCtD
Conjugated Estrogens—Vomiting—Gemcitabine—lung cancer	3.34e-05	0.000287	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Docetaxel—lung cancer	3.32e-05	0.000285	CcSEcCtD
Conjugated Estrogens—Somnolence—Docetaxel—lung cancer	3.31e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—lung cancer	3.31e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Rash—Gemcitabine—lung cancer	3.31e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Dermatitis—Gemcitabine—lung cancer	3.31e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Etoposide—lung cancer	3.31e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—lung cancer	3.29e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—lung cancer	3.29e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Headache—Gemcitabine—lung cancer	3.29e-05	0.000282	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—lung cancer	3.28e-05	0.000282	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Docetaxel—lung cancer	3.28e-05	0.000282	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—lung cancer	3.26e-05	0.00028	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—lung cancer	3.25e-05	0.000279	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Docetaxel—lung cancer	3.24e-05	0.000278	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Paclitaxel—lung cancer	3.24e-05	0.000278	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—lung cancer	3.23e-05	0.000277	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—lung cancer	3.22e-05	0.000277	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Docetaxel—lung cancer	3.22e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Asthenia—Etoposide—lung cancer	3.22e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Fatigue—Docetaxel—lung cancer	3.21e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Nausea—Irinotecan—lung cancer	3.2e-05	0.000275	CcSEcCtD
Conjugated Estrogens—Constipation—Docetaxel—lung cancer	3.19e-05	0.000274	CcSEcCtD
Conjugated Estrogens—Pain—Docetaxel—lung cancer	3.19e-05	0.000274	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—lung cancer	3.19e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Pruritus—Etoposide—lung cancer	3.17e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—lung cancer	3.16e-05	0.000271	CcSEcCtD
Conjugated Estrogens—Asthenia—Paclitaxel—lung cancer	3.16e-05	0.000271	CcSEcCtD
Conjugated Estrogens—Nausea—Gemcitabine—lung cancer	3.12e-05	0.000268	CcSEcCtD
Conjugated Estrogens—Vomiting—Cisplatin—lung cancer	3.11e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Pruritus—Paclitaxel—lung cancer	3.11e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—lung cancer	3.1e-05	0.000266	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—lung cancer	3.1e-05	0.000266	CcSEcCtD
Conjugated Estrogens—Rash—Cisplatin—lung cancer	3.09e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cisplatin—lung cancer	3.09e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Etoposide—lung cancer	3.07e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—lung cancer	3.06e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Docetaxel—lung cancer	3.05e-05	0.000262	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—lung cancer	3.04e-05	0.000261	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Paclitaxel—lung cancer	3.01e-05	0.000258	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—lung cancer	2.97e-05	0.000255	CcSEcCtD
Conjugated Estrogens—Dizziness—Etoposide—lung cancer	2.97e-05	0.000255	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—lung cancer	2.96e-05	0.000254	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—lung cancer	2.96e-05	0.000254	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—lung cancer	2.95e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Docetaxel—lung cancer	2.95e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Docetaxel—lung cancer	2.95e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—lung cancer	2.93e-05	0.000251	CcSEcCtD
Conjugated Estrogens—Dizziness—Paclitaxel—lung cancer	2.91e-05	0.00025	CcSEcCtD
Conjugated Estrogens—Nausea—Cisplatin—lung cancer	2.91e-05	0.00025	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—lung cancer	2.89e-05	0.000248	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—lung cancer	2.87e-05	0.000247	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—lung cancer	2.87e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—lung cancer	2.85e-05	0.000245	CcSEcCtD
Conjugated Estrogens—Vomiting—Etoposide—lung cancer	2.85e-05	0.000245	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—lung cancer	2.85e-05	0.000245	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—lung cancer	2.85e-05	0.000245	CcSEcCtD
Conjugated Estrogens—Rash—Etoposide—lung cancer	2.83e-05	0.000243	CcSEcCtD
Conjugated Estrogens—Dermatitis—Etoposide—lung cancer	2.83e-05	0.000242	CcSEcCtD
Conjugated Estrogens—Headache—Etoposide—lung cancer	2.81e-05	0.000241	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—lung cancer	2.81e-05	0.000241	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—lung cancer	2.8e-05	0.000241	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—lung cancer	2.8e-05	0.000241	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—lung cancer	2.8e-05	0.000241	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—lung cancer	2.8e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Vomiting—Paclitaxel—lung cancer	2.8e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Doxorubicin—lung cancer	2.79e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.78e-05	0.000239	CcSEcCtD
Conjugated Estrogens—Rash—Paclitaxel—lung cancer	2.77e-05	0.000238	CcSEcCtD
Conjugated Estrogens—Dermatitis—Paclitaxel—lung cancer	2.77e-05	0.000238	CcSEcCtD
Conjugated Estrogens—Nervousness—Doxorubicin—lung cancer	2.77e-05	0.000238	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—lung cancer	2.76e-05	0.000237	CcSEcCtD
Conjugated Estrogens—Headache—Paclitaxel—lung cancer	2.76e-05	0.000236	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Docetaxel—lung cancer	2.75e-05	0.000236	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—lung cancer	2.74e-05	0.000235	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—lung cancer	2.69e-05	0.000231	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—lung cancer	2.69e-05	0.000231	CcSEcCtD
Conjugated Estrogens—Asthenia—Docetaxel—lung cancer	2.68e-05	0.00023	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—lung cancer	2.67e-05	0.000229	CcSEcCtD
Conjugated Estrogens—Nausea—Etoposide—lung cancer	2.67e-05	0.000229	CcSEcCtD
Conjugated Estrogens—Pruritus—Docetaxel—lung cancer	2.64e-05	0.000226	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—lung cancer	2.64e-05	0.000226	CcSEcCtD
Conjugated Estrogens—Nausea—Paclitaxel—lung cancer	2.61e-05	0.000224	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—lung cancer	2.61e-05	0.000224	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—lung cancer	2.6e-05	0.000223	CcSEcCtD
Conjugated Estrogens—Vertigo—Doxorubicin—lung cancer	2.56e-05	0.00022	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—lung cancer	2.56e-05	0.00022	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—lung cancer	2.56e-05	0.000219	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Docetaxel—lung cancer	2.55e-05	0.000219	CcSEcCtD
Conjugated Estrogens—Palpitations—Doxorubicin—lung cancer	2.52e-05	0.000216	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—lung cancer	2.51e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—lung cancer	2.51e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—lung cancer	2.49e-05	0.000213	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—lung cancer	2.47e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Dizziness—Docetaxel—lung cancer	2.47e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—lung cancer	2.45e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—lung cancer	2.43e-05	0.000209	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—lung cancer	2.43e-05	0.000208	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—lung cancer	2.43e-05	0.000208	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—lung cancer	2.43e-05	0.000208	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—lung cancer	2.42e-05	0.000208	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—lung cancer	2.41e-05	0.000207	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.41e-05	0.000207	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—lung cancer	2.4e-05	0.000206	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—lung cancer	2.39e-05	0.000205	CcSEcCtD
Conjugated Estrogens—Vomiting—Docetaxel—lung cancer	2.37e-05	0.000203	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—lung cancer	2.37e-05	0.000203	CcSEcCtD
Conjugated Estrogens—Rash—Docetaxel—lung cancer	2.35e-05	0.000202	CcSEcCtD
Conjugated Estrogens—Dermatitis—Docetaxel—lung cancer	2.35e-05	0.000202	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—lung cancer	2.34e-05	0.0002	CcSEcCtD
Conjugated Estrogens—Headache—Docetaxel—lung cancer	2.34e-05	0.0002	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—lung cancer	2.33e-05	0.0002	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—lung cancer	2.33e-05	0.0002	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—lung cancer	2.32e-05	0.000199	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—lung cancer	2.32e-05	0.000199	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—lung cancer	2.31e-05	0.000198	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—lung cancer	2.3e-05	0.000197	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—lung cancer	2.29e-05	0.000196	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—lung cancer	2.28e-05	0.000196	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—lung cancer	2.27e-05	0.000195	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—lung cancer	2.26e-05	0.000194	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—lung cancer	2.25e-05	0.000193	CcSEcCtD
Conjugated Estrogens—Anorexia—Doxorubicin—lung cancer	2.22e-05	0.00019	CcSEcCtD
Conjugated Estrogens—Nausea—Docetaxel—lung cancer	2.21e-05	0.00019	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—lung cancer	2.2e-05	0.000189	CcSEcCtD
Conjugated Estrogens—Hypotension—Doxorubicin—lung cancer	2.17e-05	0.000187	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—lung cancer	2.13e-05	0.000183	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—lung cancer	2.12e-05	0.000182	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—lung cancer	2.12e-05	0.000182	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.12e-05	0.000182	CcSEcCtD
Conjugated Estrogens—Insomnia—Doxorubicin—lung cancer	2.1e-05	0.000181	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Doxorubicin—lung cancer	2.09e-05	0.000179	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—lung cancer	2.07e-05	0.000178	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—lung cancer	2.07e-05	0.000177	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—lung cancer	2.05e-05	0.000176	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—lung cancer	2.02e-05	0.000174	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—lung cancer	2.01e-05	0.000172	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—lung cancer	2.01e-05	0.000172	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—lung cancer	1.99e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—lung cancer	1.99e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—lung cancer	1.98e-05	0.00017	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—lung cancer	1.93e-05	0.000165	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—lung cancer	1.9e-05	0.000163	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—lung cancer	1.9e-05	0.000163	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—lung cancer	1.85e-05	0.000159	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—lung cancer	1.84e-05	0.000158	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—lung cancer	1.84e-05	0.000158	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—lung cancer	1.84e-05	0.000158	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—lung cancer	1.78e-05	0.000152	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—lung cancer	1.71e-05	0.000147	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—lung cancer	1.71e-05	0.000147	CcSEcCtD
Conjugated Estrogens—Rash—Methotrexate—lung cancer	1.69e-05	0.000145	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—lung cancer	1.69e-05	0.000145	CcSEcCtD
Conjugated Estrogens—Headache—Methotrexate—lung cancer	1.68e-05	0.000144	CcSEcCtD
Conjugated Estrogens—Asthenia—Doxorubicin—lung cancer	1.67e-05	0.000143	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—lung cancer	1.65e-05	0.000141	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—lung cancer	1.6e-05	0.000137	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—lung cancer	1.59e-05	0.000137	CcSEcCtD
Conjugated Estrogens—Dizziness—Doxorubicin—lung cancer	1.54e-05	0.000132	CcSEcCtD
Conjugated Estrogens—Vomiting—Doxorubicin—lung cancer	1.48e-05	0.000127	CcSEcCtD
Conjugated Estrogens—Rash—Doxorubicin—lung cancer	1.47e-05	0.000126	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—lung cancer	1.47e-05	0.000126	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—lung cancer	1.46e-05	0.000125	CcSEcCtD
Conjugated Estrogens—Nausea—Doxorubicin—lung cancer	1.38e-05	0.000119	CcSEcCtD
Conjugated Estrogens—ABCB1—Metabolism—HPGDS—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IGF1R—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCC3—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SDC4—lung cancer	2.76e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPP2R1B—lung cancer	2.75e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CREBBP—lung cancer	2.75e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HES1—lung cancer	2.72e-06	3.3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTT1—lung cancer	2.69e-06	3.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKR1C1—lung cancer	2.68e-06	3.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CG—lung cancer	2.67e-06	3.24e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.66e-06	3.23e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GCLC—lung cancer	2.66e-06	3.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2A6—lung cancer	2.66e-06	3.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CB—lung cancer	2.61e-06	3.17e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CD—lung cancer	2.61e-06	3.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.61e-06	3.16e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—UGT1A1—lung cancer	2.6e-06	3.15e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—lung cancer	2.59e-06	3.14e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ALB—lung cancer	2.58e-06	3.12e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—APOA1—lung cancer	2.58e-06	3.12e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—POMC—lung cancer	2.54e-06	3.08e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CG—lung cancer	2.54e-06	3.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ENO1—lung cancer	2.52e-06	3.05e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.52e-06	3.05e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MDM2—lung cancer	2.51e-06	3.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—RRM1—lung cancer	2.51e-06	3.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA3—lung cancer	2.51e-06	3.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNG11—lung cancer	2.51e-06	3.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—RAF1—lung cancer	2.5e-06	3.04e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTEN—lung cancer	2.5e-06	3.03e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.5e-06	3.03e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB3—lung cancer	2.49e-06	3.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CREBBP—lung cancer	2.48e-06	3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—lung cancer	2.48e-06	3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CB—lung cancer	2.45e-06	2.96e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MTOR—lung cancer	2.45e-06	2.96e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CD4—lung cancer	2.44e-06	2.96e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—lung cancer	2.42e-06	2.94e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—POMC—lung cancer	2.42e-06	2.93e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALDOA—lung cancer	2.39e-06	2.9e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—EP300—lung cancer	2.39e-06	2.89e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—lung cancer	2.38e-06	2.89e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—B4GALT5—lung cancer	2.36e-06	2.86e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	2.36e-06	2.86e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CREBBP—lung cancer	2.35e-06	2.85e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CG—lung cancer	2.35e-06	2.85e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CD—lung cancer	2.35e-06	2.85e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—lung cancer	2.34e-06	2.84e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ALB—lung cancer	2.32e-06	2.81e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA3—lung cancer	2.32e-06	2.81e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGFR1—lung cancer	2.32e-06	2.81e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—lung cancer	2.3e-06	2.79e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA4—lung cancer	2.3e-06	2.79e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIF1A—lung cancer	2.28e-06	2.76e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.28e-06	2.76e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CB—lung cancer	2.28e-06	2.76e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2E1—lung cancer	2.26e-06	2.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—lung cancer	2.26e-06	2.74e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ADCY1—lung cancer	2.26e-06	2.73e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCG2—lung cancer	2.26e-06	2.73e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—lung cancer	2.25e-06	2.73e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA2—lung cancer	2.24e-06	2.71e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—POMC—lung cancer	2.24e-06	2.71e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NQO1—lung cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CD—lung cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HPGDS—lung cancer	2.21e-06	2.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO2—lung cancer	2.21e-06	2.68e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ALB—lung cancer	2.2e-06	2.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APOA1—lung cancer	2.2e-06	2.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.2e-06	2.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KDR—lung cancer	2.18e-06	2.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CREBBP—lung cancer	2.18e-06	2.64e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.17e-06	2.63e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—lung cancer	2.16e-06	2.62e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA1—lung cancer	2.16e-06	2.62e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—EP300—lung cancer	2.15e-06	2.61e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTT1—lung cancer	2.15e-06	2.6e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCC3—lung cancer	2.14e-06	2.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.13e-06	2.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2A6—lung cancer	2.12e-06	2.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GCLC—lung cancer	2.12e-06	2.57e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—lung cancer	2.12e-06	2.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.11e-06	2.56e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—lung cancer	2.11e-06	2.56e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKR1C1—lung cancer	2.07e-06	2.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CD—lung cancer	2.07e-06	2.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CB—lung cancer	2.05e-06	2.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ALB—lung cancer	2.04e-06	2.47e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—lung cancer	2.03e-06	2.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EP300—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—STK11—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO1—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APC—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CG—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KIT—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—UGT1A1—lung cancer	2.01e-06	2.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2e-06	2.43e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGF—lung cancer	1.99e-06	2.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.98e-06	2.4e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—lung cancer	1.97e-06	2.38e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SRC—lung cancer	1.96e-06	2.38e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CB—lung cancer	1.95e-06	2.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNG11—lung cancer	1.94e-06	2.35e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—lung cancer	1.93e-06	2.34e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—POMC—lung cancer	1.91e-06	2.32e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BRAF—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NRAS—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—EP300—lung cancer	1.88e-06	2.27e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6R—lung cancer	1.87e-06	2.26e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTP1—lung cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CREBBP—lung cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALDOA—lung cancer	1.84e-06	2.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAT—lung cancer	1.81e-06	2.2e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAPK3—lung cancer	1.81e-06	2.19e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2E1—lung cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CB—lung cancer	1.8e-06	2.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA3—lung cancer	1.79e-06	2.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—lung cancer	1.79e-06	2.16e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NQO1—lung cancer	1.78e-06	2.16e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAP2K1—lung cancer	1.78e-06	2.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—lung cancer	1.77e-06	2.15e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CD—lung cancer	1.77e-06	2.14e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—lung cancer	1.77e-06	2.14e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—lung cancer	1.77e-06	2.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—lung cancer	1.76e-06	2.13e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MAPK3—lung cancer	1.75e-06	2.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.75e-06	2.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ADCY1—lung cancer	1.74e-06	2.11e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCG2—lung cancer	1.74e-06	2.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMS—lung cancer	1.73e-06	2.1e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.73e-06	2.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—lung cancer	1.72e-06	2.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTM1—lung cancer	1.71e-06	2.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO2—lung cancer	1.71e-06	2.07e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HPGDS—lung cancer	1.71e-06	2.07e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—lung cancer	1.7e-06	2.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.7e-06	2.06e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—EP300—lung cancer	1.69e-06	2.05e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—lung cancer	1.68e-06	2.04e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTT1—lung cancer	1.66e-06	2.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GCLC—lung cancer	1.64e-06	1.98e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2A6—lung cancer	1.64e-06	1.98e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1A1—lung cancer	1.62e-06	1.97e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—lung cancer	1.62e-06	1.97e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ERCC2—lung cancer	1.61e-06	1.95e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—STK11—lung cancer	1.61e-06	1.95e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—EP300—lung cancer	1.6e-06	1.94e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—lung cancer	1.59e-06	1.93e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—lung cancer	1.58e-06	1.92e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RAF1—lung cancer	1.58e-06	1.91e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—lung cancer	1.56e-06	1.89e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—lung cancer	1.56e-06	1.89e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO1—lung cancer	1.55e-06	1.88e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CB—lung cancer	1.54e-06	1.87e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MTOR—lung cancer	1.54e-06	1.87e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.51e-06	1.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—lung cancer	1.49e-06	1.81e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTP1—lung cancer	1.49e-06	1.8e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—EP300—lung cancer	1.48e-06	1.8e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—lung cancer	1.48e-06	1.79e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAT—lung cancer	1.45e-06	1.75e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—lung cancer	1.44e-06	1.75e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.44e-06	1.74e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—lung cancer	1.42e-06	1.72e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—lung cancer	1.41e-06	1.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCB1—lung cancer	1.41e-06	1.71e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—APOA1—lung cancer	1.39e-06	1.69e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2E1—lung cancer	1.39e-06	1.69e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—lung cancer	1.39e-06	1.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMS—lung cancer	1.38e-06	1.68e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—lung cancer	1.38e-06	1.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—lung cancer	1.38e-06	1.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NQO1—lung cancer	1.38e-06	1.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JUN—lung cancer	1.38e-06	1.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTM1—lung cancer	1.37e-06	1.66e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—lung cancer	1.34e-06	1.62e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—lung cancer	1.33e-06	1.62e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—lung cancer	1.33e-06	1.61e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—lung cancer	1.32e-06	1.6e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—lung cancer	1.3e-06	1.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1A1—lung cancer	1.3e-06	1.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ERCC2—lung cancer	1.29e-06	1.56e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CG—lung cancer	1.27e-06	1.54e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EP300—lung cancer	1.27e-06	1.54e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—lung cancer	1.25e-06	1.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—STK11—lung cancer	1.24e-06	1.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SRC—lung cancer	1.23e-06	1.5e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—lung cancer	1.22e-06	1.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—POMC—lung cancer	1.21e-06	1.47e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—lung cancer	1.2e-06	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—lung cancer	1.19e-06	1.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NRAS—lung cancer	1.19e-06	1.44e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.19e-06	1.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—lung cancer	1.18e-06	1.43e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CREBBP—lung cancer	1.18e-06	1.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTP1—lung cancer	1.15e-06	1.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK3—lung cancer	1.14e-06	1.38e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—lung cancer	1.13e-06	1.37e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CD—lung cancer	1.12e-06	1.35e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAT—lung cancer	1.12e-06	1.35e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—APOA1—lung cancer	1.11e-06	1.35e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—lung cancer	1.11e-06	1.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ALB—lung cancer	1.1e-06	1.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—lung cancer	1.1e-06	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCB1—lung cancer	1.09e-06	1.32e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—lung cancer	1.08e-06	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMS—lung cancer	1.07e-06	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.06e-06	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTM1—lung cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—lung cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—lung cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CG—lung cancer	1.01e-06	1.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1A1—lung cancer	1e-06	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ERCC2—lung cancer	9.92e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CB—lung cancer	9.74e-07	1.18e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—lung cancer	9.69e-07	1.17e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—POMC—lung cancer	9.66e-07	1.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—lung cancer	9.65e-07	1.17e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CREBBP—lung cancer	9.41e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—lung cancer	9.39e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—lung cancer	9.08e-07	1.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—lung cancer	8.97e-07	1.09e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CD—lung cancer	8.92e-07	1.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALB—lung cancer	8.81e-07	1.07e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—lung cancer	8.68e-07	1.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—APOA1—lung cancer	8.58e-07	1.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—lung cancer	8.42e-07	1.02e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—lung cancer	8.31e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—EP300—lung cancer	8.03e-07	9.73e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CG—lung cancer	7.83e-07	9.5e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CB—lung cancer	7.78e-07	9.43e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—lung cancer	7.71e-07	9.34e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—lung cancer	7.67e-07	9.29e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—POMC—lung cancer	7.46e-07	9.04e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CREBBP—lung cancer	7.26e-07	8.8e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CD—lung cancer	6.89e-07	8.35e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALB—lung cancer	6.8e-07	8.24e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—lung cancer	6.72e-07	8.15e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—EP300—lung cancer	6.41e-07	7.77e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CB—lung cancer	6e-07	7.28e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—lung cancer	5.95e-07	7.21e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—lung cancer	5.94e-07	7.2e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—lung cancer	5.19e-07	6.29e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—EP300—lung cancer	4.95e-07	6e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—lung cancer	4.85e-07	5.88e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—lung cancer	4.74e-07	5.75e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—lung cancer	3.87e-07	4.7e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—lung cancer	3.66e-07	4.44e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—lung cancer	2.99e-07	3.62e-06	CbGpPWpGaD
